The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk. Choosing between these two stocks may come down to ...

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...

Moderna Inc. MRNA shares fell Friday after the company reported a quarterly net loss driven by a litigation settlement charge ...

Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...

Americans have two options for a new omicron-specific Covid booster shot: Pfizer or Moderna. Which one should you get? The short answer: It mostly depends on what you're eligible for. Stream Los ...

Pfizer is by far the larger and better-established drugmaker. With a market cap of $156 billion, the pharmaceutical leader boasts a deep product portfolio across several therapeutic areas. Even with a ...